341 related articles for article (PubMed ID: 32181154)
1. Next-Generation Sequencing for Clinical Management of Multiple Myeloma: Ready for Prime Time?
Bolli N; Genuardi E; Ziccheddu B; Martello M; Oliva S; Terragna C
Front Oncol; 2020; 10():189. PubMed ID: 32181154
[TBL] [Abstract][Full Text] [Related]
2. Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: An evidence-based review from the Cancer Genomics Consortium working group for plasma cell disorders.
Pugh TJ; Fink JM; Lu X; Mathew S; Murata-Collins J; Willem P; Fang M;
Cancer Genet; 2018 Dec; 228-229():184-196. PubMed ID: 30393007
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma.
Yellapantula V; Hultcrantz M; Rustad EH; Wasserman E; Londono D; Cimera R; Ciardiello A; Landau H; Akhlaghi T; Mailankody S; Patel M; Medina-Martinez JS; Arango Ossa JE; Levine MF; Bolli N; Maura F; Dogan A; Papaemmanuil E; Zhang Y; Landgren O
Blood Cancer J; 2019 Dec; 9(12):101. PubMed ID: 31827071
[TBL] [Abstract][Full Text] [Related]
4. [Genome sequencing and personalized medicine: perspectives and limitations].
Le Gall JY; Debré P;
Bull Acad Natl Med; 2014 Jan; 198(1):101-17. PubMed ID: 26259290
[TBL] [Abstract][Full Text] [Related]
5. Delineating the Complex Genomic Landscape of Multiple Myeloma Using Next-Generation Sequencing (NGS): Progress and Potential to Supersede Traditional Genetic Testing.
Garcia-Heras J
J Assoc Genet Technol; 2020; 46(3):131-134. PubMed ID: 32889805
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of Plant Productivity in the Post-Genomics Era.
Thao NP; Tran LS
Curr Genomics; 2016 Aug; 17(4):295-6. PubMed ID: 27499678
[TBL] [Abstract][Full Text] [Related]
7. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
[TBL] [Abstract][Full Text] [Related]
8. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
9. Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma.
Oliva S; D'Agostino M; Boccadoro M; Larocca A
Front Oncol; 2020; 10():1. PubMed ID: 32076595
[TBL] [Abstract][Full Text] [Related]
10. Next-Generation Sequencing: The Translational Medicine Approach from "Bench to Bedside to Population".
Beigh MM
Medicines (Basel); 2016 Jun; 3(2):. PubMed ID: 28930123
[TBL] [Abstract][Full Text] [Related]
11. A scoping study to explore the cost-effectiveness of next-generation sequencing compared with traditional genetic testing for the diagnosis of learning disabilities in children.
Beale S; Sanderson D; Sanniti A; Dundar Y; Boland A
Health Technol Assess; 2015 Jun; 19(46):1-90. PubMed ID: 26132578
[TBL] [Abstract][Full Text] [Related]
12. Utilizing next-generation sequencing in the management of multiple myeloma.
Lionetti M; Neri A
Expert Rev Mol Diagn; 2017 Jul; 17(7):653-663. PubMed ID: 28524737
[TBL] [Abstract][Full Text] [Related]
13. Pros and Cons for Fluorescent
Ikbal Atli E; Gurkan H; Onur Kirkizlar H; Atli E; Demir S; Yalcintepe S; Kalkan R; Demir AM
Balkan J Med Genet; 2020 Nov; 23(2):59-64. PubMed ID: 33816073
[TBL] [Abstract][Full Text] [Related]
14. Next-generation sequencing for cancer diagnostics: a practical perspective.
Meldrum C; Doyle MA; Tothill RW
Clin Biochem Rev; 2011 Nov; 32(4):177-95. PubMed ID: 22147957
[TBL] [Abstract][Full Text] [Related]
15. Minimal Residual Disease in Multiple Myeloma: State of the Art and Applications in Clinical Practice.
Gozzetti A; Raspadori D; Bacchiarri F; Sicuranza A; Pacelli P; Ferrigno I; Tocci D; Bocchia M
J Pers Med; 2020 Sep; 10(3):. PubMed ID: 32927719
[TBL] [Abstract][Full Text] [Related]
16. [Advances in multiple myeloma molecular biology research].
Hanamura I
Rinsho Ketsueki; 2019; 60(9):1236-1242. PubMed ID: 31597849
[TBL] [Abstract][Full Text] [Related]
17. Methods in virus diagnostics: from ELISA to next generation sequencing.
Boonham N; Kreuze J; Winter S; van der Vlugt R; Bergervoet J; Tomlinson J; Mumford R
Virus Res; 2014 Jun; 186():20-31. PubMed ID: 24361981
[TBL] [Abstract][Full Text] [Related]
18. Genomic testing in myeloid malignancy.
Docking TR; Karsan A
Int J Lab Hematol; 2019 May; 41 Suppl 1():117-125. PubMed ID: 31069982
[TBL] [Abstract][Full Text] [Related]
19. Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls.
Horak P; Fröhling S; Glimm H
ESMO Open; 2016; 1(5):e000094. PubMed ID: 27933214
[TBL] [Abstract][Full Text] [Related]
20. NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial.
Rosa-Rosa JM; Cuenca I; Medina A; Vázquez I; Sánchez-delaCruz A; Buenache N; Sánchez R; Jiménez C; Rosiñol L; Gutiérrez NC; Ruiz-Heredia Y; Barrio S; Oriol A; Martin-Ramos ML; Blanchard MJ; Ayala R; Ríos-Tamayo R; Sureda A; Hernández MT; de la Rubia J; Alkorta-Aranburu G; Agirre X; Bladé J; Mateos MV; Lahuerta JJ; San-Miguel JF; Calasanz MJ; Garcia-Sanz R; Martínez-Lopez J
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
